![](/img/cover-not-exists.png)
Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, LeslieLanguage:
english
Journal:
International Journal of Clinical Practice
DOI:
10.1111/ijcp.13030
Date:
October, 2017
File:
PDF, 997 KB
english, 2017